AS Pro Kapital Grupp (TAL:PKG1T)
Estonia · Delayed Price · Currency is EUR 1.320
-0.010 (-0.75%)
At close: Jul 30, 2025
Blueprint Medicines Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
| 27.55 | 18.16 | 23.02 | 65.65 | 43.1 | 13.64 | Upgrade | |
Revenue Growth (YoY) | 117.65% | -21.12% | -64.94% | 52.35% | 216.01% | -75.33% | Upgrade |
Cost of Revenue | 18.81 | 12.74 | 15.99 | 48.69 | 32.52 | 9.42 | Upgrade |
Gross Profit | 8.74 | 5.42 | 7.03 | 16.97 | 10.58 | 4.21 | Upgrade |
Selling, General & Admin | 6.24 | 6.14 | 5.87 | 5.14 | 5.76 | 4.59 | Upgrade |
Other Operating Expenses | 0.31 | 0.29 | 0.28 | 0.33 | 0.38 | 0.37 | Upgrade |
Operating Expenses | 6.55 | 6.43 | 6.15 | 5.47 | 6.14 | 4.96 | Upgrade |
Operating Income | 2.19 | -1.01 | 0.88 | 11.5 | 4.44 | -0.75 | Upgrade |
Interest Expense | -2.58 | -2.82 | -3.83 | -4.19 | -5.95 | -5.39 | Upgrade |
Interest & Investment Income | 0.09 | 0.12 | 0.25 | 0 | 0.01 | 0 | Upgrade |
Currency Exchange Gain (Loss) | - | - | - | - | - | -0 | Upgrade |
Other Non Operating Income (Expenses) | -1.37 | -1.46 | -0.29 | -0.02 | -0.02 | -0.03 | Upgrade |
EBT Excluding Unusual Items | -1.66 | -5.16 | -2.98 | 7.29 | -1.52 | -6.16 | Upgrade |
Gain (Loss) on Sale of Assets | - | - | 0.11 | 2.33 | 28.84 | - | Upgrade |
Asset Writedown | 1.13 | 1.13 | 1.97 | 3.83 | 5.54 | 2.89 | Upgrade |
Other Unusual Items | - | - | - | - | 1 | 0.35 | Upgrade |
Pretax Income | -0.53 | -4.03 | -0.9 | 13.45 | 33.86 | -2.93 | Upgrade |
Income Tax Expense | -0.25 | -0.16 | 0 | -0 | -0.01 | 0.35 | Upgrade |
Earnings From Continuing Operations | -0.29 | -3.88 | -0.9 | 13.45 | 33.87 | -3.28 | Upgrade |
Earnings From Discontinued Operations | - | - | - | - | -4.12 | -56.18 | Upgrade |
Net Income to Company | -0.29 | -3.88 | -0.9 | 13.45 | 29.76 | -59.46 | Upgrade |
Minority Interest in Earnings | 0.31 | 0.2 | - | - | - | 3.78 | Upgrade |
Net Income | 0.02 | -3.68 | -0.9 | 13.45 | 29.76 | -55.68 | Upgrade |
Net Income to Common | 0.02 | -3.68 | -0.9 | 13.45 | 29.76 | -55.68 | Upgrade |
Net Income Growth | - | - | - | -54.79% | - | - | Upgrade |
Shares Outstanding (Basic) | 57 | 57 | 57 | 57 | 57 | 57 | Upgrade |
Shares Outstanding (Diluted) | 57 | 57 | 57 | 57 | 57 | 57 | Upgrade |
EPS (Basic) | 0.00 | -0.06 | -0.02 | 0.24 | 0.52 | -0.98 | Upgrade |
EPS (Diluted) | 0.00 | -0.06 | -0.02 | 0.24 | 0.52 | -0.98 | Upgrade |
EPS Growth | - | - | - | -54.79% | - | - | Upgrade |
Free Cash Flow | -7.45 | -10.49 | 8.34 | 16.19 | 13.11 | -7.75 | Upgrade |
Free Cash Flow Per Share | -0.13 | -0.18 | 0.15 | 0.29 | 0.23 | -0.14 | Upgrade |
Gross Margin | 31.73% | 29.87% | 30.53% | 25.84% | 24.54% | 30.89% | Upgrade |
Operating Margin | 7.96% | -5.55% | 3.82% | 17.52% | 10.30% | -5.46% | Upgrade |
Profit Margin | 0.07% | -20.24% | -3.91% | 20.49% | 69.05% | -408.29% | Upgrade |
Free Cash Flow Margin | -27.03% | -57.79% | 36.23% | 24.67% | 30.43% | -56.83% | Upgrade |
EBITDA | 3.75 | 0.27 | 1.19 | 11.77 | 4.68 | -0.48 | Upgrade |
EBITDA Margin | 13.61% | 1.46% | 5.17% | 17.93% | 10.85% | -3.53% | Upgrade |
D&A For EBITDA | 1.56 | 1.27 | 0.31 | 0.27 | 0.24 | 0.26 | Upgrade |
EBIT | 2.19 | -1.01 | 0.88 | 11.5 | 4.44 | -0.75 | Upgrade |
EBIT Margin | 7.96% | -5.55% | 3.82% | 17.52% | 10.30% | -5.46% | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.